tiprankstipranks
Advertisement
Advertisement

SRRK Stock Latest News

Scholar Rock Charts High-Stakes Path to SMA Launch
Company AnnouncementsScholar Rock Charts High-Stakes Path to SMA Launch
1d ago
SRRK
Scholar Rock Charts Path to Apitegromab Approval
PremiumCompany Announcements
Scholar Rock Charts Path to Apitegromab Approval
13d ago
SRRK
JPMorgan places Scholar Rock on ‘Positive Catalyst Watch’
PremiumThe Fly
JPMorgan places Scholar Rock on ‘Positive Catalyst Watch’
13d ago
SRRK
Scholar Rock price target raised to $55 from $53 at Barclays
PremiumThe Fly
Scholar Rock price target raised to $55 from $53 at Barclays
13d ago
SRRK
Scholar Rock price target raised to $65 from $58 at H.C. Wainwright
PremiumThe Fly
Scholar Rock price target raised to $65 from $58 at H.C. Wainwright
13d ago
SRRK
Scholar Rock reports Q1 EPS (83c), consensus (78c)
PremiumThe FlyScholar Rock reports Q1 EPS (83c), consensus (78c)
14d ago
SRRK
Scholar Rock Advances Apitegromab Toward Potential 2026 Launches
Premium
Company Announcements
Scholar Rock Advances Apitegromab Toward Potential 2026 Launches
14d ago
8K
SRRK
Scholar Rock initiated with a Buy at Canaccord
Premium
The Fly
Scholar Rock initiated with a Buy at Canaccord
1M ago
SRRK
Scholar Rock initiated with a Buy at Canaccord
PremiumThe Fly
Scholar Rock initiated with a Buy at Canaccord
1M ago
SRRK
Scholar Rock price target raised to $57 from $54 at Jefferies
PremiumThe Fly
Scholar Rock price target raised to $57 from $54 at Jefferies
2M ago
SRRK
De-Risked Regulatory Path and Manufacturing Readiness Underpin Buy Rating on Apitegromab
PremiumRatings
De-Risked Regulatory Path and Manufacturing Readiness Underpin Buy Rating on Apitegromab
2M ago
SRRK
Morning News Wrap-Up 3/31/26: Today’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up 3/31/26: Today’s Biggest Stock Market Stories!
2M ago
UL
AMD
Scholar Rock price target raised to $58 from $51 at BofA
PremiumThe FlyScholar Rock price target raised to $58 from $51 at BofA
2M ago
SRRK
Apitegromab: Strengthened Regulatory Position and Dual-Site Strategy De-Risk Approval and Commercialization
Premium
Ratings
Apitegromab: Strengthened Regulatory Position and Dual-Site Strategy De-Risk Approval and Commercialization
2M ago
SRRK
Scholar Rock resubmission ‘material de-risking event,’ says H.C. Wainwright
Premium
The Fly
Scholar Rock resubmission ‘material de-risking event,’ says H.C. Wainwright
2M ago
SRRK
Scholar Rock price target raised to $60 from $53 at Raymond James
PremiumThe Fly
Scholar Rock price target raised to $60 from $53 at Raymond James
2M ago
SRRK
Scholar Rock Resubmits Apitegromab BLA, Expands Manufacturing Plans
PremiumCompany Announcements
Scholar Rock Resubmits Apitegromab BLA, Expands Manufacturing Plans
2M ago
8K
SRRK
Scholar Rock rises 15.5%
PremiumThe Fly
Scholar Rock rises 15.5%
2M ago
SRRK
What Sent Scholar Rock Holding Stock (SRRK) Higher Today?
PremiumMarket News
What Sent Scholar Rock Holding Stock (SRRK) Higher Today?
2M ago
NVO
SRRK
Scholar Rock up 12% at $48.27 after resubmitting BLA to FDA for apitegromab
PremiumThe FlyScholar Rock up 12% at $48.27 after resubmitting BLA to FDA for apitegromab
2M ago
SRRK
Scholar Rock resubmits BLA to FDA for apitegromab
Premium
The Fly
Scholar Rock resubmits BLA to FDA for apitegromab
2M ago
SRRK
Scholar Rock extends rally after Cantor note, shares up 14% to $45.34
Premium
The Fly
Scholar Rock extends rally after Cantor note, shares up 14% to $45.34
2M ago
SRRK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >